06/16/2026
CVC Catalyst to Acquire Majority Stake in WillowWood from Blue Sea Capital, the Arbogast Family and Management
Mt. Sterling, OH, June 16, 2026 – CVC Catalyst III (“CVC Catalyst”) has agreed to acquire a majority stake in WillowWood Holdings Inc. (“WillowWood” or the “Company”). CVC Catalyst will become the majority investor alongside Blue Sea Capital (“Blue Sea”), the Arbogast family and Management, who are reinvesting substantially alongside CVC. Mahesh Mansukhani and Daniel Rubin (co-CEOs of WillowWood) will continue to lead the business and Ryan Arbogast, a fourth-generation member of the founding Arbogast family, will continue to play a key role in supporting the mission of the Company. Financial terms of the transaction were not disclosed.
WillowWood is one of the leading manufacturers of prosthetic products, including prosthetic liners, feet, knees, and other technologies, across the US and key European markets. Founded in 1907 in Mt. Sterling, Ohio by William E. Arbogast, a bilateral amputee who lost both legs in a railroad accident, WillowWood has spent more than 115 years committed to leveling the playing field for people experiencing limb loss through innovation and the pursuit of the best possible clinical outcomes. The Company pioneered the gel liner, a critical interface between a patient’s residual limb and their prosthesis, and remains the go-to liner brand for patients and prosthetists, offering approximately 1,000 SKUs alongside custom liner capabilities that solve the most challenging cases. This has been complemented by a fast-growing feet, knees and custom-fabrication portfolio to give amputees the mobility they are seeking.
To read the full press release, click here:
Leading Prosthetic Company | WillowWood® - Comfort & Functionality Since 1907